Skip to content

Smoking Cessation Program With CBT and Mindfulness Audio Support: A Randomized Controlled Trial

Protocol for a Smoking Cessation Program With CBT Text and Mindfulness Audio Support: A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06901713
Enrollment
2000
Registered
2025-03-30
Start date
2024-10-09
Completion date
2026-11-01
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation; Tobacco Dependence

Brief summary

This protocol describes a randomized controlled trial evaluating the effectiveness of a smoking cessation program with two intervention methods. One method provides only CBT text messages (Group A), while the other combines CBT text with mindfulness audio (Group B). The study aims to compare the two approaches in reducing smoking frequency, managing cravings, and improving emotional regulation. This study investigates the effects of two different smoking cessation interventions: (1) CBT text-based program alone (Group A), and (2) CBT text combined with mindfulness audio (Group B). The primary outcomes include reductions in smoking frequency and cravings, as well as improvements in emotional regulation and quality of life.

Detailed description

Design: A randomized controlled trial (RCT) will be used to compare the outcomes of the two intervention groups. Setting: The study will be conducted online. Participants will access the CBT text materials through a dedicated platform and the mindfulness audio via a compatible device. Recruitment will be done through social media, community outreach, and online advertisements.

Interventions

OTHERcognitive behaviour thearpy

Participants will access the CBT text materials through a dedicated platform

OTHERmindfulness

Participants will access the mindfulness audio via a compatible device

Sponsors

Sir Run Run Shaw Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Who smoke at least 5 cigarettes per day. * Express a desire to quit or reduce smoking. * Who has the ability to access and use the provided digital materials.

Exclusion criteria

* Those currently enrolled in other smoking cessation programs. * Individuals with severe psychiatric disorders that may interfere with participation. * Those without access to the necessary digital devices.

Design outcomes

Primary

MeasureTime frameDescription
Biological Verification of Abstinence6 MonthsConfirmation of smoking abstinence at the end of the study period using cotinine test strips. This will be the main measure to assess the effectiveness of the smoking cessation interventions.

Secondary

MeasureTime frameDescription
Smoking FrequencyBaseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 26.Measured by the number of cigarettes smoked per day at baseline
Craving IntensityBaseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 26.Assessed using a visual analog scale (VAS)
Emotional RegulationBaseline, Week 12, and Week 26Evaluated using the Depression, Anxiety, and Stress Scale (DASS-21)

Countries

China

Contacts

Primary ContactYanhui Liao
liaoyanhui@zju.edu.cn86 18814898844

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026